Enhancing Readability of Lay Abstracts and Summaries for Medical Knowledge Using Generative Artificial Intelligence (BRIDGE AI 3)

Part of paid clinical trials in Los Angeles, California.

Sponsor
University of Southern California
Study ID
NCT07568444
Phase
PHASE2
Status
Completed

Conditions

  • Bladder Cancer
  • Kidney Cancers
  • Prostate Cancer (Adenocarcinoma)
  • Testis Cancer

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Pub2Post — OTHER
    Pub2Post, a generative artificial intelligence agent which helps in drafting the layperson abstracts and summaries

Study Details

This trial tests if AI can help make medical info clear and readable. Many patients struggle to find medical informations that easy to read and understand from verified medical sources. The study tests if an AI tool can assist health providers to craft clear text for patients more fast than what they do now. Health providers are split at random into two groups-one uses the AI tool and one does not. The trial tests how clear the text is, how correct it is, and how much time is saved. The aim is to see if AI can close the gap between complex research and what patients can grasp.

Key Dates

Start date
Jan 16, 2025
Status verified
May 2026
Primary completion
Jan 22, 2025
Completion
Feb 27, 2025

Study Design

Enrollment
120 participants (actual)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • No Intervention: Gold Standard
  • Experimental: Pub2Post

Primary Outcome Measure

Readability Change [ Time Frame: The assessment will be conducted immediately after the study closes, which will occur 4 weeks after enrollment. ]

Locations (1)

FacilityCityStateZIPSite coordinators
University of Southern CaliforniaLos AngelesCalifornia91100-

Find similar trials in Los Angeles, CA

By condition
By specialty

Related Studies